{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,20]],"date-time":"2026-10-20T08:06:31Z","timestamp":1792483591220,"version":"4.5.0"},"reference-count":38,"publisher":"European Respiratory Society (ERS)","issue":"152","license":[{"start":{"date-parts":[[2019,4,17]],"date-time":"2019-04-17T00:00:00Z","timestamp":1555459200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"content-domain":{"domain":["publications.ersnet.org"],"crossmark-restriction":true},"short-container-title":["Eur Respir Rev"],"accepted":{"date-parts":[[2019,3,8]]},"published-print":{"date-parts":[[2019,6,30]]},"abstract":"<jats:p>The results of the randomised controlled trials investigating the bronchoscopic lung volume reduction treatment using endobronchial valves (EBV) are promising, and have led to their inclusion in treatment guidelines, US Food and Drug Administration approval and inclusion in routine care in an increasing number of countries. The one-way valve treatment has advanced and is now a regular treatment option. However, this new phase will lead to new challenges in terms of implementation. We believe that key issues in future research concern advanced patient selection, improved methods for target lobe selection, increased knowledge on the predictive risk of a pneumothorax, positioning of pulmonary rehabilitation in conjunction with the EBV treatment, the positioning of lung volume reduction surgery<jats:italic>versus<\/jats:italic>EBV treatment, and the long-term efficacy, adverse events, impact on exacerbations and hospitalisations, costs and survival. Hopefully, the increasing number of patients treated, the setup of (inter)national registries and future research efforts will further optimise all aspects of this treatment.<\/jats:p>","DOI":"10.1183\/16000617.0121-2018","type":"journal-article","created":{"date-parts":[[2019,4,17]],"date-time":"2019-04-17T12:56:26Z","timestamp":1555505786000},"page":"180121","update-policy":"https:\/\/doi.org\/10.1183\/ers-crossmark-policy","source":"Crossref","is-referenced-by-count":71,"title":["Endobronchial valves for severe emphysema"],"prefix":"10.1183","volume":"28","author":[{"given":"Jorine E.","family":"Hartman","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4387-4096","authenticated-orcid":false,"given":"Lowie E.G.W.","family":"Vanfleteren","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eva M.","family":"van Rikxoort","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karin","family":"Klooster","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dirk-Jan","family":"Slebos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"81","published-online":{"date-parts":[[2019,4,17]]},"reference":[{"key":"2024102403385648000_28.152.180121.1","doi-asserted-by":"crossref","first-page":"1535","DOI":"10.1164\/rccm.201707-1327OC","article-title":"A multicenter randomized controlled trial of zephyr endobronchial valve treatment in heterogeneous emphysema (TRANSFORM)","volume":"196","author":"Kemp","year":"2017","journal-title":"Am J Respir Crit Care Med"},{"key":"2024102403385648000_28.152.180121.2","doi-asserted-by":"crossref","first-page":"1151","DOI":"10.1164\/rccm.201803-0590OC","article-title":"A multicenter randomized controlled trial of zephyr endobronchial valve treatment in heterogeneous emphysema (LIBERATE)","volume":"198","author":"Criner","year":"2018","journal-title":"Am J Respir Crit Care Med"},{"key":"2024102403385648000_28.152.180121.3","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1507807"},{"key":"2024102403385648000_28.152.180121.4","doi-asserted-by":"crossref","first-page":"1073","DOI":"10.1164\/rccm.201607-1383OC","article-title":"Endobronchial valve therapy in patients with homogeneous emphysema. Results from the IMPACT Study","volume":"194","author":"Valipour","year":"2016","journal-title":"Am J Respir Crit Care Med"},{"key":"2024102403385648000_28.152.180121.5","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(15)60001-0"},{"key":"2024102403385648000_28.152.180121.6","unstructured":"US Food and Drug Administration . FDA approval: Zephyr Endobronchial Valve System. www.accessdata.fda.gov\/cdrh_docs\/pdf18\/P180002a.pdf Date last updated: June 29 2018. Date last accessed: October 14, 2018."},{"key":"2024102403385648000_28.152.180121.7","unstructured":"National Institute for Health and Care Excellence . Endobronchial valve insertion to reduce lung volume in emphysema. www.nice.org.uk\/guidance\/IPG600\/chapter\/1-Recommendations Date last updated: December 2017. Date last accessed: October 14, 2018."},{"key":"2024102403385648000_28.152.180121.8","doi-asserted-by":"publisher","DOI":"10.1164\/rccm.201701-0218PP"},{"key":"2024102403385648000_28.152.180121.9","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1159\/000453588","article-title":"Endobronchial valves for endoscopic lung volume reduction: best practice recommendations from Expert Panel on Endoscopic Lung Volume Reduction","volume":"93","author":"Slebos","year":"2017","journal-title":"Respiration"},{"key":"2024102403385648000_28.152.180121.10","doi-asserted-by":"publisher","DOI":"10.1159\/000259318"},{"key":"2024102403385648000_28.152.180121.11","doi-asserted-by":"crossref","first-page":"1539","DOI":"10.5588\/ijtld.16.0033","article-title":"Endobronchial valve treatment of destructive multidrug-resistant tuberculosis","volume":"20","author":"Levin","year":"2016","journal-title":"Int J Tuberc Lung Dis"},{"key":"2024102403385648000_28.152.180121.12","doi-asserted-by":"publisher","DOI":"10.1510\/icvts.2010.236398"},{"key":"2024102403385648000_28.152.180121.13","doi-asserted-by":"crossref","unstructured":"Hartman JE , Klooster K , Groen H , et\u00a0al. Cost-effectiveness of endobronchial valve treatment in patients with severe emphysema compared to standard medical care. Respirology 2018; in press [https:\/\/doi.org\/10.1111\/resp.13295].","DOI":"10.1111\/resp.13295"},{"key":"2024102403385648000_28.152.180121.14","doi-asserted-by":"publisher","DOI":"10.1164\/rccm.201103-0455CI"},{"key":"2024102403385648000_28.152.180121.15","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa030287"},{"key":"2024102403385648000_28.152.180121.16","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1016\/j.rmed.2016.06.009","article-title":"Improvement of physical activity after endobronchial valve treatment in emphysema patients","volume":"117","author":"Hartman","year":"2016","journal-title":"Respir Med"},{"key":"2024102403385648000_28.152.180121.17","doi-asserted-by":"publisher","DOI":"10.1183\/09031936.00015312"},{"key":"2024102403385648000_28.152.180121.18","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa0900928"},{"key":"2024102403385648000_28.152.180121.19","doi-asserted-by":"crossref","unstructured":"Gompelmann D , Benjamin N , Bischoff E , et\u00a0al. Survival after endoscopic valve therapy in patients with severe emphysema. Respiration 2019: 145\u2013152.","DOI":"10.1159\/000492274"},{"key":"2024102403385648000_28.152.180121.20","doi-asserted-by":"publisher","DOI":"10.1159\/000360642"},{"key":"2024102403385648000_28.152.180121.21","doi-asserted-by":"crossref","unstructured":"Li S , Wang G , Wang C , et\u00a0al. The REACH Trial: A Randomized Controlled Trial Assessing the Safety and Effectiveness of the Spiration Valve System in the Treatment of Severe Emphysema. Respiration 2018; in press [https:\/\/doi.org\/10.1159\/000494327].","DOI":"10.1159\/000494327"},{"key":"2024102403385648000_28.152.180121.22","first-page":"OA1465","article-title":"The REACH study, a randomized controlled trial assessing the safety and effectiveness of the Spiration Valve System endobronchial therapy for severe emphysema: 12 month follow-up results","volume":"50","author":"Wang","year":"2017","journal-title":"Eur Respir J"},{"key":"2024102403385648000_28.152.180121.23","doi-asserted-by":"publisher","DOI":"10.1183\/13993003.congress-2018.OA4928"},{"key":"2024102403385648000_28.152.180121.24","doi-asserted-by":"crossref","first-page":"A598","DOI":"10.1016\/j.jval.2014.08.2068","article-title":"Cost-effectiveness of endobronchial valve therapy for severe emphysema: a model-based projection based on the Vent study","volume":"17","author":"Pietzsch","year":"2014","journal-title":"Value Health"},{"key":"2024102403385648000_28.152.180121.25","doi-asserted-by":"crossref","first-page":"882","DOI":"10.1109\/TMI.2015.2500279","article-title":"Automatic pulmonary artery-vein separation and classification in computed tomography using tree partitioning and peripheral vessel matching","volume":"35","author":"Charbonnier","year":"2016","journal-title":"IEEE Trans Med Imaging"},{"key":"2024102403385648000_28.152.180121.26","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/j.media.2016.11.001","article-title":"Improving airway segmentation in computed tomography using leak detection with convolutional networks","volume":"36","author":"Charbonnier","year":"2017","journal-title":"Med Image Anal"},{"key":"2024102403385648000_28.152.180121.27","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1159\/000448849","article-title":"Predicting lung volume reduction after endobronchial valve therapy is maximized using a combination of diagnostic tools","volume":"92","author":"Koster","year":"2016","journal-title":"Respiration"},{"key":"2024102403385648000_28.152.180121.28","doi-asserted-by":"crossref","first-page":"1767","DOI":"10.2147\/COPD.S106439","article-title":"Predictors of pneumothorax following endoscopic valve therapy in patients with severe emphysema","volume":"11","author":"Gompelmann","year":"2016","journal-title":"Int J Chron Obstruct Pulmon Dis"},{"key":"2024102403385648000_28.152.180121.29","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1159\/000477258","article-title":"Pleural adhesion assessment as a predictor for pneumothorax after endobronchial valve treatment","volume":"94","author":"van Geffen","year":"2017","journal-title":"Respiration"},{"key":"2024102403385648000_28.152.180121.30","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1159\/000491675","article-title":"Bronchoscopic lung volume reduction treatment using endobronchial valves for emphysema: emerging questions","volume":"96","author":"Hartman","year":"2018","journal-title":"Respiration"},{"key":"2024102403385648000_28.152.180121.31","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1159\/000453529","article-title":"One-year follow-up after endobronchial valve treatment in patients with emphysema without collateral ventilation treated in the STELVIO trial","volume":"93","author":"Klooster","year":"2017","journal-title":"Respiration"},{"key":"2024102403385648000_28.152.180121.32","doi-asserted-by":"publisher","DOI":"10.1183\/09031936.00071311"},{"key":"2024102403385648000_28.152.180121.33","doi-asserted-by":"crossref","first-page":"170","DOI":"10.21037\/jovs.2017.10.04","article-title":"Bronchoscopic lung volume reduction with endobronchial valves for heterogeneous emphysema: long-term results","volume":"3","author":"Fiorelli","year":"2017","journal-title":"J Vis Surg"},{"key":"2024102403385648000_28.152.180121.34","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1164\/rccm.201604-0852LE","article-title":"Survival after endobronchial valve placement for emphysema: a 10-year follow-up study","volume":"194","author":"Garner","year":"2016","journal-title":"Am J Respir Crit Care Med"},{"key":"2024102403385648000_28.152.180121.35","doi-asserted-by":"crossref","first-page":"1272","DOI":"10.1164\/rccm.201610-1993LE","article-title":"Improved predictors of survival after endobronchial valve treatment in patients with severe emphysema","volume":"195","author":"Klooster","year":"2017","journal-title":"Am J Respir Crit Care Med"},{"key":"2024102403385648000_28.152.180121.36","doi-asserted-by":"publisher","DOI":"10.1183\/09031936.00100110"},{"key":"2024102403385648000_28.152.180121.37","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1159\/000448119","article-title":"A long-term follow-up investigation of endobronchial valves in emphysema (the LIVE Study): study protocol and six-month interim analysis results of a prospective five-year observational study","volume":"92","author":"Skowasch","year":"2016","journal-title":"Respiration"},{"key":"2024102403385648000_28.152.180121.38","unstructured":"BreathGroup . Registry. www.breathgroup.eu\/registry.html Date last accessed: January 30, 2019."}],"container-title":["European Respiratory Review"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1183\/16000617.0121-2018","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,24]],"date-time":"2025-02-24T05:00:57Z","timestamp":1740373257000},"score":1,"resource":{"primary":{"URL":"https:\/\/publications.ersnet.org\/lookup\/doi\/10.1183\/16000617.0121-2018"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,4,17]]},"references-count":38,"journal-issue":{"issue":"152","published-online":{"date-parts":[[2019,4,17]]},"published-print":{"date-parts":[[2019,6,30]]}},"alternative-id":["10.1183\/16000617.0121-2018"],"URL":"https:\/\/doi.org\/10.1183\/16000617.0121-2018","relation":{},"ISSN":["0905-9180","1600-0617"],"issn-type":[{"value":"0905-9180","type":"print"},{"value":"1600-0617","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,4,17]]}}}